基本信息
views: 3
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
As a clinician scientist, my research interests focus on the patient. My clinical interest as an ophthalmologist is glaucoma. Ultimately I am interested in research that will have concrete benefit to the patient, whether it be by developing a potential new treatments or by the clinical study of disease progression and how that is modified by treatment. Glaucoma is the leading of irreversible blindness in the world. The condition involves progressive death of retinal ganglion cells (RGC) in the eye resulting in irreversible visual loss. We don’t truly understand how or why this happens. Recent evidence suggests that neuronal death in glaucoma has common mechanisms with other neurodegenerative conditions such as Alzheimer’s and Parkinson’s disease. Thus, advances in our understanding of glaucoma may have implications for other brain diseases and we can learn and translate breakthrough findings from those related research fields to glaucoma research.
Research Interests
Papers共 141 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Lakni Shahanika Weerasinghe,Hamish Paul Dunn,Adrian T Fung,Glen Maberly,Ngai Wah Cheung, Daminda P Weerasinghe,Gerald Liew,Helen Do,Tien-Ming Hng,Alison Pryke,Samuel I Marks,Helen Nguyen,
BMJ open diabetes research & careno. 4 (2023): e003376-e003376
PloS oneno. 1 (2023): e0280937-e0280937
Ruben Hemelings,Bart Elen,Alexander K. Schuster,Matthew B. Blaschko,João Barbosa-Breda,Pekko Hujanen, Annika Junglas,Stefan Nickels,Andrew White, Norbert Pfeiffer,Paul Mitchell,Patrick De Boever,
npj Digital Medicineno. 1 (2023): 1-15
Experimental eye research (2023): 109409-109409
David P Holmes,Colin I Clement,Vuong Nguyen,Paul R Healey,Ridia Lim,Andrew White, Joshua Yuen,Mitchell Lawlor
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn